2025-03-24 - Analysis Report
## Procter & Gamble Co (PG) Stock Review

**0. Overview & Key Figures:**

Procter & Gamble Co (PG) is a consumer goods company producing and marketing a wide range of products.

* **Cumulative Return (PG):** 77.64%
* **Cumulative Return (VOO/S&P 500):** 104.98%
* **Return Difference (PG vs VOO):** -27.3%
* **Relative Divergence:** 23.5% (This means PG's underperformance relative to the S&P 500 is in the 23.5th percentile of its historical range of divergence.  It is not necessarily a negative indicator, especially in the context of the following analysis.)


**1. Alpha & Beta Analysis:**

The provided data shows a mixed performance of PG compared to the S&P 500, as reflected by its alpha.  While the CAGR (Compound Annual Growth Rate) is positive in most periods, the alpha fluctuates between negative and positive values, indicating periods of both outperformance and underperformance relative to the market benchmark.  The beta generally hovers around 1, suggesting PG's price movements have a similar volatility to the overall market.  The Market capitalization consistently increased over the years. Note that the MDD (Maximum Drawdown) values are relatively low, compared to other high-growth or high-risk stocks.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 20.0% | 1.8% | -8.0% | 0.0 | 177.8 |
| 2016-2018  | 13.0% | 6.8% | 0.3 | 184.2 |
| 2017-2019  | 43.0% | 6.8% | 0.9 | 257.3 |
| 2018-2020  | 57.0% | 8.2% | 0.3 | 293.7 |
| 2019-2021  | 65.0% | 8.2% | 0.2 | 354.0 |
| 2020-2022  | 15.0% | 8.5% | 0.2 | 336.1 |
| 2021-2023  | 8.0% | 8.5% | 0.5 | 333.2 |
| 2022-2024  | -5.0% | 8.5% | 0.4 | 390.7 |
| 2023-2025  | 18.0% | 8.3% | 0.2 | 390.9 |


**2. Recent Price Movement:**

* **Closing Price:** $166.69
* **5-Day Moving Average:** $168.06
* **20-Day Moving Average:** $171.44
* **60-Day Moving Average:** $167.31

The price is currently below all three moving averages, suggesting a downtrend.  The recent price change (-$0.51) indicates a minor decrease, not a significant event.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.42 (Medium Risk)
* **RSI:** 28.6 (Oversold; potential for a bounce)
* **PPO:** -0.52 (Bearish)
* **Relative Divergence Change (20-day):** -2.6 (Short-term downtrend)
* **Expected Return (2+ years):** -11.6% (This suggests a potential underperformance relative to the S&P 500 over the long term.)  This negative expected return should be carefully considered in light of the overall analysis.


**4. Recent Earnings Analysis:**

The earnings data shows relatively stable revenue, hovering around $21B, with some fluctuation. EPS (Earnings Per Share) has also shown a general upward trend, albeit not consistently.

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2025-01-22 | 1.94 | $21.88B      |
| 2024-10-18 | 1.65 | $21.74B      |
| 2024-04-19 | 1.56 | $20.20B      |
| 2024-01-23 | 1.44 | $21.44B      |
| 2023-01-22 | 1.44 | $21.44B      |


**5. Financial Information:**

The financial data reveals consistent revenue and relatively high profit margins.  ROE (Return on Equity) fluctuates, suggesting varying efficiency in utilizing shareholder equity.  Overall, the financial health appears stable, although ROE needs closer inspection of underlying drivers of changes in the efficiency of capital utilization.


| Quarter     | Revenue      | Profit Margin | Equity     | ROE     |
|-------------|---------------|---------------|-------------|---------|
| 2024-12-31 | $21.88B      | 52.39%        | $51.17B    | 9.05%   |
| 2024-09-30 | $21.74B      | 52.06%        | $51.84B    | 7.64%   |
| 2024-06-30 | $20.53B      | 49.60%        | $50.29B    | 6.24%   |
| 2024-03-31 | $20.20B      | 51.20%        | $50.06B    | 7.50%   |
| 2023-12-31 | $21.44B      | 52.69%        | $48.53B    | 7.15%   |


**6. Overall Analysis:**

PG shows a relatively stable financial profile with consistent revenue and profitability. However, its stock performance has lagged behind the S&P 500 recently. While technical indicators suggest potential for a short-term bounce, the negative expected return and the relatively lower cumulative return compared to the market indicate a need for caution.  The negative expected return, in particular, requires thorough review of the underlying assumptions and data used to generate this forecast. The investor should weigh the companyâ€™s strong fundamentals against its recent underperformance relative to the market before making any investment decisions.  Further research into the drivers of the negative alpha and the potential for improvement in the future is necessary.  A deeper dive into the specific reasons behind fluctuations in ROE would also provide additional insights.
